151 related articles for article (PubMed ID: 9436035)
1. Cell cycle control during hematopoietic cell differentiation.
Furukawa Y
Hum Cell; 1997 Sep; 10(3):159-64. PubMed ID: 9436035
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle regulation of hematopoietic stem cells.
Furukawa Y
Hum Cell; 1998 Jun; 11(2):81-92. PubMed ID: 9777402
[TBL] [Abstract][Full Text] [Related]
3. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells.
Gill RM; Slack R; Kiess M; Hamel PA
Exp Cell Res; 1998 Oct; 244(1):157-70. PubMed ID: 9770359
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
Hu X; Cress WD; Zhong Q; Zuckerman KS
Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate.
Jiang H; Lin J; Young SM; Goldstein NI; Waxman S; Davila V; Chellappan SP; Fisher PB
Oncogene; 1995 Sep; 11(6):1179-89. PubMed ID: 7566979
[TBL] [Abstract][Full Text] [Related]
6. Control of E2F activity by p21Waf1/Cip1.
Delavaine L; La Thangue NB
Oncogene; 1999 Sep; 18(39):5381-92. PubMed ID: 10498892
[TBL] [Abstract][Full Text] [Related]
7. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation.
Sidle A; Palaty C; Dirks P; Wiggan O; Kiess M; Gill RM; Wong AK; Hamel PA
Crit Rev Biochem Mol Biol; 1996 Jun; 31(3):237-71. PubMed ID: 8817077
[TBL] [Abstract][Full Text] [Related]
8. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering.
Alesse E; Zazzeroni F; Angelucci A; Giannini G; Di Marcotullio L; Gulino A
Cell Death Differ; 1998 May; 5(5):381-9. PubMed ID: 10200487
[TBL] [Abstract][Full Text] [Related]
9. Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431.
Ahmad N; Gupta S; Mukhtar H
Oncogene; 1999 Mar; 18(10):1891-6. PubMed ID: 10086343
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of P19 EC cells leads to differential modulation of cyclin-dependent kinase activities and to changes in the cell cycle profile.
Kranenburg O; de Groot RP; Van der Eb AJ; Zantema A
Oncogene; 1995 Jan; 10(1):87-95. PubMed ID: 7824282
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells.
Zhu WY; Jones CS; Kiss A; Matsukuma K; Amin S; De Luca LM
Exp Cell Res; 1997 Aug; 234(2):293-9. PubMed ID: 9260897
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of a specific cdk site in E2F-1 affects its electrophoretic mobility and promotes pRB-binding in vitro.
Peeper DS; Keblusek P; Helin K; Toebes M; van der Eb AJ; Zantema A
Oncogene; 1995 Jan; 10(1):39-48. PubMed ID: 7824278
[TBL] [Abstract][Full Text] [Related]
13. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
[TBL] [Abstract][Full Text] [Related]
14. E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation.
Strom DK; Cleveland JL; Chellappan S; Nip J; Hiebert SW
Cell Growth Differ; 1998 Jan; 9(1):59-69. PubMed ID: 9438389
[TBL] [Abstract][Full Text] [Related]
15. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
Morris L; Allen KE; La Thangue NB
Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
[TBL] [Abstract][Full Text] [Related]
16. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
17. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.
Fan G; Ma X; Kren BT; Steer CJ
Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of p21waf1 leads to increased inhibition of E2F-1 phosphorylation and sensitivity to anticancer drugs in retinoblastoma-negative human sarcoma cells.
Li WW; Fan J; Hochhauser D; Bertino JR
Cancer Res; 1997 Jun; 57(11):2193-9. PubMed ID: 9187120
[TBL] [Abstract][Full Text] [Related]
19. Characterization of an E2F-p130 complex formed during growth arrest.
Corbeil HB; Branton PE
Oncogene; 1997 Aug; 15(6):657-68. PubMed ID: 9264406
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
Hiyama H; Iavarone A; Reeves SA
Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
